These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 29713465)

  • 1. Estimating the burden of antimicrobial resistance: a systematic literature review.
    Naylor NR; Atun R; Zhu N; Kulasabanathan K; Silva S; Chatterjee A; Knight GM; Robotham JV
    Antimicrob Resist Infect Control; 2018; 7():58. PubMed ID: 29713465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol.
    Naylor NR; Silva S; Kulasabanathan K; Atun R; Zhu N; Knight GM; Robotham J
    Syst Rev; 2016 Nov; 5(1):187. PubMed ID: 27821153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
    Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
    Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the best available data to estimate the cost of antimicrobial resistance: a systematic review.
    Wozniak TM; Barnsbee L; Lee XJ; Pacella RE
    Antimicrob Resist Infect Control; 2019; 8():26. PubMed ID: 30733860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.
    Tappenden P; Campbell F; Rawdin A; Wong R; Kalita N
    Health Technol Assess; 2012; 16(20):1-72. PubMed ID: 22490205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
    Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
    Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
    Ayinde O; Ross JDC; Jackson L
    PLoS One; 2023; 18(10):e0292273. PubMed ID: 37856496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study.
    Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L
    Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review.
    Tolley A; Bansal A; Murerwa R; Howard Dicks J
    J Antimicrob Chemother; 2024 Jun; 79(6):1248-1269. PubMed ID: 38498622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic literature review of economic evaluation studies of interventions impacting antimicrobial resistance.
    Painter C; Faradiba D; Chavarina KK; Sari EN; Teerawattananon Y; Aluzaite K; Ananthakrishnan A
    Antimicrob Resist Infect Control; 2023 Jul; 12(1):69. PubMed ID: 37443104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of liraglutide in type II diabetes: a systematic review.
    Zueger PM; Schultz NM; Lee TA
    Pharmacoeconomics; 2014 Nov; 32(11):1079-91. PubMed ID: 25052903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand.
    Phodha T; Riewpaiboon A; Malathum K; Coyte PC
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):305-312. PubMed ID: 30321493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
    Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
    Elife; 2023 Aug; 12():. PubMed ID: 37534878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
    Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
    Anopa Y; Conway DI
    Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.